These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 26027830)
21. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Price MO; Price FW Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779 [TBL] [Abstract][Full Text] [Related]
22. Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer. Xie L; Shi W; Wang Z; Bei J; Wang S Cornea; 2001 Oct; 20(7):748-52. PubMed ID: 11588429 [TBL] [Abstract][Full Text] [Related]
23. Interleukin-1 receptor antagonist eye drops promoting high-risk corneal allografts survival in rats. Jie Y; Zhang WH; Pan ZQ; Wu YY; Wang Y Chin Med J (Engl); 2004 May; 117(5):711-6. PubMed ID: 15161539 [TBL] [Abstract][Full Text] [Related]
24. Local therapy of corneal allograft rejection with cyclosporine. Zhao JC; Jin XY Am J Ophthalmol; 1995 Feb; 119(2):189-94. PubMed ID: 7832225 [TBL] [Abstract][Full Text] [Related]
25. [Effects of 1alpha, 25-dihydroxyvitamin D3 on the acute immune rejection and corneal neovascularization in high-risk penetrating keratoplasty in rats]. Dang ST; Lu XH; Zhou J; Bai L Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):892-6, 903. PubMed ID: 15321754 [TBL] [Abstract][Full Text] [Related]
26. Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty. Fei WL; Chen JQ; Yuan J; Quan DP; Zhou SY J Ocul Pharmacol Ther; 2008 Apr; 24(2):235-44. PubMed ID: 18321198 [TBL] [Abstract][Full Text] [Related]
27. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft]. Shi WY; Liu T; Xie LX; Wang SG Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204 [TBL] [Abstract][Full Text] [Related]
28. The effect of corticosteroid and cyclosporin A on murine corneal allograft rejection. Zhang EP; Schulte F; Bulfone-Paus S; Hoffmann F Graefes Arch Clin Exp Ophthalmol; 2000 Jun; 238(6):525-30. PubMed ID: 10943679 [TBL] [Abstract][Full Text] [Related]
29. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats]. Zhang W; Pan Z; Zhai C Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411 [TBL] [Abstract][Full Text] [Related]
30. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas. Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987 [TBL] [Abstract][Full Text] [Related]
31. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830 [TBL] [Abstract][Full Text] [Related]
32. CsA downregulates IFN-gamma gene transcription after liver transplantation by inhibiting NF-kappa B activity. Jia C; Zheng S; Xie H Chin Med J (Engl); 2003 Nov; 116(11):1668-72. PubMed ID: 14642132 [TBL] [Abstract][Full Text] [Related]
33. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. Pan Q; Xu Q; Boylan NJ; Lamb NW; Emmert DG; Yang JC; Tang L; Heflin T; Alwadani S; Eberhart CG; Stark WJ; Hanes J J Control Release; 2015 Mar; 201():32-40. PubMed ID: 25576786 [TBL] [Abstract][Full Text] [Related]
34. [Long-term results of FK 506 eye drops following corneal transplantation]. Reis A; Mayweg S; Birnbaum F; Reinhard T Klin Monbl Augenheilkd; 2008 Jan; 225(1):57-61. PubMed ID: 18236371 [TBL] [Abstract][Full Text] [Related]
35. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection. Tabbara KF Int Ophthalmol; 2008 Jun; 28(3):223-32. PubMed ID: 17634865 [TBL] [Abstract][Full Text] [Related]
36. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression. du Toit D; Muller C; Page B; Louw J Microsc Res Tech; 1998 Nov; 43(4):347-55. PubMed ID: 9849976 [TBL] [Abstract][Full Text] [Related]
37. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Benelli U; Ross JR; Nardi M; Klintworth GK Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):274-82. PubMed ID: 9040459 [TBL] [Abstract][Full Text] [Related]
38. [Ciclosporin down-regulates interferon-gamma gene transcription via its inhibition of nuclear factor kappaB activity after liver transplantation]. Jia CK; Zheng SS; Shi SH; Zhang AB; Xie HY Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1052-5. PubMed ID: 15498318 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats. Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400 [TBL] [Abstract][Full Text] [Related]